The SEC secured over $17m in penalties against defendants who ran a fraudulent medical device investment scheme.
The SEC secured over $17m in penalties against defendants who ran a fraudulent medical device investment scheme.
Elanco’s use of sales incentives created misleading impressions of customer demand, the SEC stated.
Five SEC enforcement actions include allegations that some advisers’ recommendations were not in the best interest of clients.
The four settlements come nearly one year after the SEC sued SolarWinds for misleading investors about its cybersecurity controls.
The allegations revolve around hundreds of episodes of unlawful trading in the secondary (cash) market for US Treasuries.
Charges filed against broker-dealer and parent company over access to confidential trading information.
Disciplinary decisions issued June 9 – June 15, 2023.
Disciplinary decisions issued May 19 – May 25, 2023.